SCHEMBL7861710

SCHEMBL7861710

C=CCOC(=O)C(CCN1C(=O)c2ccccc2C1=O)(CC(=O)c1ccc(Br)cc1)C(=O)OCC=C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 1/20 0.49
NPSR1 Q6W5P4 1/20 0.47
POLB P06746 2/20 0.45
CYP3A4 P08684 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.38
KMT2A Q03164 2/20 0.37
MEN1 O00255 1/20 0.37
MMP1 P03956 1/20 0.37
MMP2 P08253 1/20 0.37
MMP9 P14780 1/20 0.37
MMP14 P50281 1/20 0.37
ADAM17 P78536 1/20 0.37
NPC1 O15118 1/20 0.37
GAA P10253 1/20 0.36
ALDH1A1 P00352 1/20 0.36
CASP3 P42574 1/20 0.36
BCL2L2 Q92843 1/20 0.35
ATM Q13315 1/20 0.35
USP2 O75604 1/20 0.35
MAPK1 P28482 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7861865 0.82 THRA (0.41) NPSR1POLBSMN1; SMN2GAA
SCHEMBL7862778 0.81 GSK3B (0.59) GSK3BPOLBCYP3A4SMN1; SMN2KMT2A
SCHEMBL7860396 0.73 NPC1 (0.60) NPSR1POLBCYP3A4KMT2AMEN1
SCHEMBL3025973 0.71 GSK3B (0.72) GSK3BPOLBCYP3A4SMN1; SMN2KMT2A
SCHEMBL6293053 0.70 MMP2 (0.43) GSK3BSMN1; SMN2MMP2MMP9NPC1
SCHEMBL4262187 0.69 MAPT (0.43) KMT2AMEN1MMP1ALDH1A1MAPK1
SCHEMBL14711680 0.68 GSK3B (1.00) GSK3BNPSR1POLBCYP3A4SMN1; SMN2
SCHEMBL7574583 0.67 MEN1 (0.46) NPSR1KMT2AMEN1MMP1MMP2
SCHEMBL6296941 0.67 NPC1 (0.42) POLBSMN1; SMN2KMT2AMEN1MMP2
SCHEMBL23388863 0.67 ALDH1A1 (0.46) NPSR1SMN1; SMN2KMT2AMEN1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0923529-B1 SUBSTITUTE 4-ARYLBUTYRIC ACID DERIVATIVES AS MATRIX METALLOPROTEASE INHIBITORS BAYER AG (US) 2001-09-19 EP disclosed
CN-1225620-A Substituted 4-arylbutanoic acid derivatives as matrix metalloproteinase inhibitors BAYER AG (US) 1999-08-11 CN disclosed
EP-0923529-A1 SUBSITUTE 4-ARYLBUTYRIC ACID DERIVATIVES AS MATRIX METALLOPROTEASE INHIBITORS Bayer Corporation (US) 1999-06-23 EP disclosed
US-5863915-A ENZYME INHIBITORS FOR BONES AND JOINTS BAYER CORPORATION (US) 1999-01-26 US disclosed
WO-1997043237-A1 SUBSITUTE 4-ARYLBUTYRIC ACID DERIVATIVES AS MATRIX METALLOPROTEASE INHIBITORS BAYER CORPORATION (US) 1997-11-20 WO disclosed